• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND SENTRANT INTRODUCER SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND SENTRANT INTRODUCER SHEATH; INTRODUCER, CATHETER Back to Search Results
Model Number SENSH1628W
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 10/03/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B5; additional information received: the estimated blood loss for the patient was 20 cc.A new sheath was opened while the physician applied pressure to control the bleeding.No additional intervention was required.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
A 16f sentrant sheath ((b)(6)) was intended to be used as a conduit during an unknown endovascular treatment.It was reported during the index procedure, the sheath was placed in the patient and upon removal of the dilator, the sentrant sheath malfunctioned, leading to significant blood loss, though no patient injury occurred.No damage was observed on the sheath itself, but slight damage and bend to the was noted.The 16f sheath was replaced for a new sheath, which successfully controlled the bleeding.The ifu was followed when using the sentrant.Per the physician the cause hemostatic valve leak was not determined.No additional clinical sequelae were reported, and the patient is fine.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Device evaluation summary: the sentrant sheath returned with the seal cap, the catheter seal and slit seal detached from the seal housing and located on the dilator.The dilator was not locked in the seal cap when received.Inspection of the seal cap tabs confirmed deformation to the seal cap tabs.The reported failure to achieve hemostatis due to detachment of the seal cap and catheter seal as confirmed through analysis.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SENTRANT INTRODUCER SHEATH
Common Device Name
INTRODUCER, CATHETER
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway,ie
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway,ie
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key20576347
Report Number9612164-2024-04992
Device Sequence Number12818700
Product Code DYB
UDI-Device Identifier00763000716257
UDI-Public(01)00763000716257(17)260323(10)P2F24C0056(20)01
Combination Product (Y/N)N
Initial Reporter StateNY
Initial Reporter CountryUS
PMA/510(K) Number
K123990
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 09/12/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/23/2026
Device Model NumberSENSH1628W
Device Catalogue NumberSENSH1628W
Device Lot NumberP2F24C0056
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/03/2024
Supplement Date Received by Manufacturer11/07/2024
12/18/2024
09/12/2025
Initial Report FDA Received Date10/31/2024
Supplement Report FDA Received Date11/08/2024
01/10/2025
09/12/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/23/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age66 YR
Patient SexMale
-
-